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Abstract 
Obsessive-compulsive disorder is a behavior disorder 
characterized by recurrent. intense thoughts and repetitive. 
ritualistic acts. Treatments for obsessive compulsive disorder 
typically consist of either exposure and response prevention or 
pharmacotherapy. particularly benzodiazepines. Combinations of 
these two types of treatment could lead to three possible 
outcomes. First. the combination of exposure and response 
prevention and benzodiazepines may show no better results than 
exposure and response prevention alone. Second. combination 
therapy may result in a better effect than exposure and response 
prevention alone--the drug will decrease anxiety during exposure 
without increasing the relapse rate after treatment. Third. 
combination therapy could have worse effects than exposure and 
response prevention alone by increasing the rate of relapse 
through state-dependent learning--Iearning occurring during the 
drugged state does not transfer to the non-drugged state. The 
purpose of this study was to assess the effects of the 
combination of exposure and response prevention with the 
benzodiazepine alprazolam using a single-subject design. This 
design alternated between exposure and response prevention plus 
alprazolam and exposure and response prevention alone. The 
results of this study show that the alprazolam condition did not 
differ from the placebo condition. suggesting that alprazolam did 
not function effectively to reduce the subject's anxiety. 
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Obsessive compulsive disorder (OCD) has a lifetime 
prevalence of 2-3% (Robins, Helzer. & Weissman. 1984). This 
estimate is much higher than previous estimates, indicating that 
OCD is almost three times more prevalent than schizophrenia 
(Greist. 1990a). As such a common disorder. it is surprising to 
note that until the last decade, most treatments for OCD have 
been largely ineffective (Jenfke. 1983). OCD treatment was 
greatly advanced with the introduction of the behavioral 
technique exposure and response prevention (Boersma. Den Hengst, 
Dekker, & Emmelkamp. 1976; Perse. 1988; G-reist, 1990a, 1990b) and 
various pharmacotherapy techniques, most notably clomipramine 
(Greist, et a1.. 1990; Trimble. 1990). Unfortunately. not all 
obsessive compulsives benefit from either of these two 
treatments; further research is warranted to discover a treatment 
method that will help all OCD patients. 
Obsessive compulsive disorder affects men and women 
approximately equally (Jenike. 1983; Rasmussen & Tsuang, 1984) 
with 60-65% of patients exhibiting an onset of the disorder 
before age 25 (Jenike, 1983; Perse. 1988; Rasmussen & Tsuang. 
1984). In about 60% of OCD cases. an identifiable precipitant 
has been noted; the most common of these precipitants are 
pregnancy and childbirth, sexual components. and death of a loved 
one. Although the course of the disorder was previously viewed 
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as chronic and deteriorating, most patients exhibit a course that 
IS episodic with periods of remission that are not complete but 
that allow for normal social functioning (Rasmussen & Tsuang, 
1984). 
According to the Diagnostic and Statistical Manual Third 
Edition Revised (American Psychiatric Association. 1987), 
obsessive compulsive disorder is defined by the presence of 
recurrent, persistent thoughts or ideas. called obsessions. and 
by repetitive, ritualistic compulsions--acts that the person 
feels compelled to do, generafly in response to the obsession. 
1'he person will perform the compulsion in an attempt to reduce 
the anxiety brought about by the obsession. but this relief is 
short-lived. Most people with this disorder have both obsessions 
and compulsions. and the DSM-IIIR states that the person must be 
aware that his/her behaviors and thoughts are unrealistic and ego 
dystonic (American Psychiatric Association. 1987). 
The most common types of obsessions are those that center 
around the fear of contamination (Rasmussen & Eisen. 1989). 
Understandably. the compulsion that accompanies this fear is 
washing. Patients will spend hours out of their day excessively 
washing their hands and bodies, their clothes. and their homes to 
remove the toxins and dirt that they believe could potentially 
harm themselves or their families. Other common compulsions are 
checking and counting. A patient who fears that she may have 
forgotten to lock the door when she left home will return to her 
home dozens of times to check the lock. Another patient may 
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count to a certain number in his head every time he has an 
obsession. 
Exposure and response prevention in the treatment of 
obsessive compulsive disorder has been shown to have success 
ratcs of up to 80~ (of patients showing marked improvement of 
symptoms) when the patients comply with the program (Perse. 
1988). Exposure and response prevention are often preferred over 
the pharmacological treatment clomipramine. a serotonin re-uptake 
inhibiting medication which has recently been approved for the 
treatment of OCD. Approximatily 24% of patients relapse after 
exposure and response prevention (Greist. 1990b), while 
approximately 90% of patients relapse after the discontinuation 
of clomipramine (Greist. et al., 1990). .Further, a number of 
patients are unable to tolerate the large side effect profile 
which accompanies the use of clomipramine (Trimble. 1990: 
Tollefson. 1985). 
Exposure and response prevention can be assisted by a 
therapist or can be done by the patient alone (possibly as a 
homework assignment given by the therapist). Exposure can be 
conducted either in vivo, where the patient actually comes into 
contact with the feared stimulus. or in imagination when the 
stimulus is too frightening or dangerous. Exposure to each 
stimulus is continued until the patient"s anxiety has decreased 
substantially. Greist (1990a) recommends that an exposure 
session last at least JO-45 minutes. but longer sessions may be 
necessary for anxiety to decrease. Response prevention requires 
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the patient to refrain from the anxiety-reducing compulsion for 
increasingly longer periods of time. 
As noted above, exposure and response prevention is the 
treatment of choice for some researchers and therapists because 
of its high success rates dUel low rates of relapse. However, up 
to 25% of patients will not comply with the anxiety-provoking, 
rigorous treatment style of the behavior therapy (Greist, 1990a). 
In order to reduce the anxiety brought about by behavior therapy, 
some researchers have proposed the combination of 
benzodiazepines and exposure and response prevention (Kamano, 
1972; Marks and Swinson, 1990: Marks, Viswanathan. Lipsedge, & 
Gardner, 1972). This combination could lead to three possible 
outcomes. First. the combination may yield no better effect than 
behavior therapy alone; in which case. the combination therapy 
would be of no clinical value. Second. the combination may 
facilitate exposure and response prevention by generating higher 
success rates than behavior therapy alone. If this is the case, 
the combination therapy would be of great clinical value-­
patients would not experience intense discomfort during the 
treatment. and thus, more patients would comply with the therapy. 
Further. with higher success rates, more patients would be 
helped. The last possible outcome of the combination therapy is 
the occurrence of state-dependent learning. State-dependent 
learning is the phenomenon in which learning that takes place 
while under the influence of a drug, such as alcohol. does not 
transfer to the non-drugged state. Thus, learning is dependent 
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upon the patient's drug state (Overton, 1064). State-dependent 
learning is very detrimental because it results in high rates of 
relapse after treatment and requires a re-Iearning of the 
information previously learned while in the drugged state. 
Several studies have been conducted to investigate state-
dependent learning. Patel, Ciofalo. and Iorio (1979) found that 
mice administered one of four benzodiazepines before the training 
of a passive-avoidance task did not exhibit the avoidance task in 
the next day's non-drugged training session. Similarly, Bouton, 
Kenney, and Rosengard (1990) found the acquisition of fear 
extinction in benzodiazepine-drugged mice to be state-dependent. 
The authors suggest that if state-dependent learning occurs in 
humans undergoing combination therapy relapse rates will be quite 
high after the drug is discontinued. 
A few studies on the effects of combined treatment in humans 
have been conducted and have found quite different results from 
the previously mentioned studies. Wardle (1990) reviewed six 
studies in which exposure plus an anxiolytic was compared to 
exposure plus placebo in the treatment of phobics. In all but 
one of these trials, acute benzodiazepine treatment was employed; 
this means that the drug was given either during or before the 
exposure sessions, never between the sessions. Wardle found that 
four of the six trials had better results with the combined 
treatment. 
Another study by Marks et al. (1972) performed using 
diazepam suggested that the drug most facilitated behavior 
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therapy with phobics when the drug was administered so that its 
effect was decreasing during the exposure sessions. I tis 
hypothesized that state-dependent learning is more likely to 
occur when the drug is having its peak effect than when the 
drug's effects arc waning. Neither of these studies reported 
patient relapse when the drug was discontinued. 
The above research was conducted using the drug diazepam, 
but one study (Marks & Swinson, 1990) was carried out combining 
the benzodiazepine alprazolam and behavior therapy in the 
treatment of agoraphobics. with much different results. The 
subjects in this study were placed on alprazolam for eight weeks, 
with an average final dose of 5 rug/day. After the drug was 
discontinued, a high number of the subjects relapsed, suggesting 
that state-dependent learning occurred. However, the studies by 
Wardle (1990) and Marks et al. (1972) suggest that the manner in 
which alprazolam was employed in this study may actually have 
created a conducive environment for relapse. For example, the 
trials reviewed by Wardle (1990) and Marks et al. (1972) 
incorporated acute benzodiazepine treatment and found evidence 
for the efficacy of combined treatment, while Marks and Swinson 
(1990) used continuous benzodiazepine treatment and found a high 
relapse rate. Unless other research is performed to study the 
effects of alpruzolam assisted exposure and response prevention, 
incorporating the use of alprazolam in the manner implicated by 
Wardle (1990) and Marks eL dl. 19721. Lhc efficacy of that 
combination may go undiscovered. 
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One such study was conducted by Bruce, Spiegal, and McGrath 
(1993) to examine the effects of alprazo]am-assisted exposure and 
response prevention in a social phobic. This study consisted of 
six units of exposure to six different tasks, with three units 
employing a placebo pill and the other three employing 0.5 mg of 
alprazolam. The results clearly showed that alprazolam 
functioned effectively to reduce the subject's anxiety, but they 
also indicated that some state-dependent learning may have 
occurred. The researchers found that learning taking place 
during alprazolam-assisted ex~osure did not transfer as well as 
learning taking place during the placebo condition, but it was 
not entirely clear whether this was the result of state-dependent 
learning or of some subject-related factor. 
Research on combined therapy using acute treatment of 
diazepam and alprazolam suggests excellent success rates with 
little or no state-dependent learning in the treatment of 
phobics. However, no published studies on the use of combined 
therapy and obsessive compulsive disorder exist. Therefore, the 
following study is proposed to test the efficacy of combined 
therapy on OCD. Following the previous research on acute 
benzodiazepine treatment in phobics, it is predicted that 
combining the short-acting benzodiazepine, alprazolam, and 
exposure and response prevention in obsessive compulsi.ve disorder 
will facilitate the behavior therapy without resulting in the 
occurrence of state-dependent learning. If the prediction is 
upheld by the results of this study, further research in this 
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area will be warranted to determine if combined treatment for 
obsessive compulsive disorder may be superior to exposure and 
response prevention alone. 
Method 
Subject 
The subject was a fifteen year old male with a primary DSM­
IIIR Axis I diagnosis of obsessive-compulsive disorder. His 
disorder centered around his obsessions of contamination. The 
subject's method of coping with the contamination was through 
excessive washing. His score on the Yale-Brown Obsessive­
Compulsive Scale (Y-BOCS) was 33, which indicated a severe, 
although self-reported, level of OCD. The subject had been on no 
medications for his disorder and had not participated in any 
other form of treatment for it. He came to the University of 
Illinois College of Medicine at Peoria in 1993 for the treatment 
of his disorder and agreed to participate in this study. 
Appar a t us _illLd--.Ma t e rj a I.§. 
The subject was monitored using the Vitalog 5000--a portable 
device designed to measure heart rate and to maintain a 
computerized account of all data. (Kozak, Foa, & Steketee (1988) 
showed that heart rate measures are highly correlated with 
anxiety). Further . .subjective ratings of anxiety (Subjective 
Units of Distress or SUDS) and the urge to wash were taken 
approximately every five minutes during each 60 minute therapist-
directed exposure session. These ratings were taken on a 0-100 
scale. Finally, before each session the subject was asked La 
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report (on a 0-100 scale) his anticipatory anxiety, his 
confidence level. and his belief that doing the upcoming exposure 
task would make the next exposure task easier. He was also asked 
to estimate his current heart rate and his maximum heart rate 
during the upcoming exposure. After each session. he was asked 
to report (on a 0-100 scale) his concentration level during the 
previous exposure task, the degree to which he was distracted 
during the task, his feeling of success for the task, his 
confidence level for future tasks, his belief that having done 
the task would make the next task easier, and his current 
anxiety. contamination level. and urge to wash. He was also 
asked to estimate his maximum heart rate during the previous 
exposure task. Finally, at the end of each day, the subject was 
asked to report whether he believed that he was given the 
alprazolam. If the subject was able to correctly report this, 
this confounding variable would have to be taken into 
consideration during data analysis. 
Procedur~ 
This study ran for 12 consecutive days, during which time, 
the subject was exposed to a series of four tasks. Exposure to 
each of tile four tasks occurred in the natural environment, 
either at the clinic. the subject's home. OT a local hospital. 
Each series required three days to complete--an active day. a 
washout day, and a state-dependent day. The active days 
consisted of four GO-minute exposure sessions. while the state-
dependent day consisted of three. No exposure sessions occurred 
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on the washout day. Once each series was complete. a new series 
of exposures began. utilizing a task which was about equal to the 
first in the amount of anxiety that was provoked. This cycle 
continued until four series had been completed. The response 
prevention rules across the entire sequence were identical. The 
subject was not allowed to wash during the exposure session or 
before eating or to change his clothes during the day. 
On the morning of the first day. the subject was 
familiarized with the Vitalog 5000 and to the subjective measures 
which were used during the ex~osure sessions. Once the 
orientation was complete, the series of exposure sessions began. 
On the first day, which was called the active day. the 
subject was given a baseline exposure task (Task A), such as 
placing his hand on a contaminated doorknob. Each exposure 
session, including the baseline task. lasted for 60 minutes. The 
baseline task allowed for the measurement of the initial values 
of the heart rate, anxiety. and urge to wash while the subject 
was in the non-drug state. 
After the baseline task. the subject was given a glass of 
orange juice which contained either 0.5 mg of alprazolam or no 
drug at all. The determination of 0.5 mg follows the study by 
Bruce, Spiegal, and McGrath (1993) and is suggested by Gitlin 
(1990) as the optimal starting dose for the treatment of acute or 
situational anxiety. The administration of the drug or the 
placebo was conducted In a double-blind fashion. An independent 
person determined 011 which two active days the drug would be 
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present and on which two the placebo would be present through a 
random lottery procedure. This person also prepared the drugged 
or non-drugged juice to insure blindness on the part of the 
therapists. To insure that the subject was completely unaware of 
when he was receiving the drug, a glass of non-drugged orange 
juice was given before each baseline task and before and after 
each post-drug exposure session. 
Beginning roughly one hour later, Task A was repeated. with 
three more 60-minute exposure sessions occurring. On the days 
when alprazolam was ingested, this time lapse allowed alprazolam 
to be at its peak of action during the first post-drug exposure 
session and gradually decreasing in effect over the next two. 
On the second day. called the washout day. the subject did 
not visit the therapist and was instructed not to practice the 
exposure techniques that he had learned. For the active days in 
which alprazolam was received, the washout day allowed time for 
most of the drug to be removed from the blood stream. 
The third day was called the state-dependent day. On this 
day. the schedule followed quite closely with that of the active 
day. Orange juice was still given at the same times as the 
active day (to insure the subjecl was blind to the administration 
of the drug), except that no drug was ever given on state-
dependent day. Task A was repeated, but only three 60 minute 
exposure sessions were given. Additionally, if the subjective 
ratings were less than or equal to 10 for 5 consecutive ratings 
(or 20 minutes). the session was terminated. 
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State-dependent day tested for the occurrence of state 
dependent learning, since the drug had enough time to be removed 
from the blood stream. If the gains made during the exposure 
sessions aided by alprazolam showed state dependency, then the 
objective (heart rate) and subjective (anxiety and urge to wash) 
measures on this day would be near those of the active day 
baseline. If no state-dependency occurred, the learning from the 
active day's exposure sessions would be evidenced by much lower 
objective and subjective measures on state-dependent day than 
those of the active day baselfne. 
Proposed DesiKn 
This study incorporated an alternating treatments design 
(ATD). This is the design of choice in studies such as this, 
because it allows the researcher to alternate between two or more 
treatment conditions fairly rapidly and to easily discriminate 
differences between the conditions. The treatment design was 
excellent for this study because it allowed for the determination 
of whether alpruzolam effectively aided exposure and response 
prevention without causing state dependent learning. 
Results 
When asked after the last trial of the active days and the 
last trial of the state-dependent days if he believed that he had 
ingested alprazolam that day, the subject reported affirmatively 
63% of the time (or five out of eight times). Of these 
affirmative reports, 40% (two out of five) were correct--he 
correctly reported that he had been given the drug on two out of 
•
 
Obsessive-Compulsive Disorder 15 
the two alprazolam-assisted active days. When asked to rate on a 
0-100 scale the degree to which his success was a result of the 
drug, the subject's average response from the two days in which 
alprazolam was ingested was 25. His average response from all 
five days in which he believed he had been given the drug was 
24.5. 
The subject was also asked to rate himself on a number of 
items before and after each exposure session. Before each 
session, the subject was asked to rate his anxiety about the 
upcoming exposure task and to 'estimate his highest heart rate for 
the upcoming task, and the results for both measures show an 
overall decrease across trials. He also reported his confidence 
level and his belief that doing the upcoming task would make the 
next task easier. Both ratings showed an overall increase across 
trials. Finally, the subject was asked to report his current 
heart rate before each task. This measure remained virtually 
unchanged across trials. 
After each session. the subject was asked to rate his 
concentration level and distraction level for the preceding 
exposure session. The subject's average concentration level 
across trials was 70.45 (out of 100), while his average 
distraction level was 19.73 (out of 100). The subject's rating 
of success for the preceding task and his ·confidence in his 
ability to do future tasks showed no obvious increases or 
decreases. The subject's average rating of success across trials 
was 76.43 (out of 100). while his average confidence level was 
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64.46 (out of 100). The subject also estimated his highest heart 
rate for the preceding trial, and this rating showed an obvious 
decline across trials, with an average rating of 87.57. The 
subject's rating that doing the previous task would make the next 
task easier showed no obvious trend. finally, the subject's 
average ratings (across trials) of his anxiety, urge to wash, and 
contamination after the exposure task were all quite 10w--2.48, 
4.21, and 3.57 (out of 100), respectively. 
The subject's Y-BOCS scores were also of interest. The 
subject's initial Y-BOeS totar score was 33 before treatment; 
this indicates a severe level of OCD. After treatment. the 
subject's score had decreased to 2. At the five month follow-up, 
the subject's score was 8. 
In order to determine if a difference existed between the 
alprazolam-assisted exposure sessions and the placebo exposure 
sessions. all data were collapsed. and a 2 X 3 factorial design 
(drug X condition) was done. The 2 X 3 ANOVA revealed a non­
significant main effect of drug, E (1. 31) = 2.77, Q > .01 and a 
non-significant main effect of condition, E (2, 31) = 3.15, Q > 
.01. figures 1 and 2 illustrate the results of this analysis-­
the two graphs show very little difference between them, 
suggesting that the drug did not exhibit an anxiolytic effect in 
the patient. for an anxiolytic effect to be present, a much 
greater reduction in Dl (the average SUDS of the first trials 
from the drug days) from baseline as compared to the placebo 
condition must be evident. and it IS not. 
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Sl (the average SUDS of trials one from the state dependent 
days following alprazolam ingestion) showed no rebounding effect, 
the major test for the occurrence of state-dependent learning 
(See Figure ll. If state-dependent learning hud occurred, it 
would have been evidenced by mean SUDS scores on Sl approximately 
equal to those of the active day baseline. 
Insert Figures 1 and 2 about here 
Since similar trends were '. faund in the urge to wash, these 
graphs are not included. Also not included is the objective 
heart rate data. It was hoped that this data could be used to 
verify the subjective ratings of anxiety .. Unfortunately, the 
Vitalog-SOOO. which is a portable device designed to monitor 
heart rate, malfunctioned early in the study, and thus, the 
desired objective data could not be obtained. 
Discussion 
Based on the results of this study, the hypothesis that 
combining the short-acting benzodiazepine alprazolam with 
exposure and response prevention would facilitate the behavior 
therapy without resulting in the occurrence of state-dependent 
learning was not upheld. No significant differences in the SUDS 
scores between the alprazolam-assisted exposure sessions and the 
placebo exposure sessions existed, suggesting that alprazolam did 
not function effectively to reduce the subject's anxiety. The 
mean SUDS scores on the state-dependent day following the 
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alprazolam-assisted act lve day showed no rebounding towards the 
active day baseline. This indicates that state-dependent 
learning did not occur. Since the drug showed no anxiolytic 
effect on the patient, it is not surprising that state-dependent 
learning did not occur. Thus. the combination therapy showed no 
better effect than exposure and response prevention alone. 
The most probable explanation of these results is that the 
dose of the drug was not high enough to result in an anxiety­
reducing effect in the subject. In addition, the subject was 
unusual in that OCD patients ienerally do not exhibit such 
immediate. marked. and generalizing relief in their symptoms as 
occurred with this subject. Also. the subject was young. had the 
disorder for only a short time. and had an unusually high initial 
Y-HOCS score. Taken together, these facts indicate that the 
results of this study arc not generalizable. More research in 
the area is necessary to obtain more generalizable results and 
thus. better knowledge about the hypothesis. 
Before concluding. a discussion of the internal and external 
validity of the study is necessary. The internal validity of the 
study is strong in that the tests administered to the subject 
(namely, the SUDS, the urge to wash. and the Y-BOeS) have been 
used in a number of studies and have been shown to be valid. The 
major threat to internal validity is that the experiment was not 
conducted in a tightly-controlled laboratory setting. Instead, 
the exposure sessions took place in the natural environment (i.e. 
in the clinic. in the patient's horne, and at a local hospital), 
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possibly allowing for the influence of extraneous variables. 
Although this impinges on the internal validity of the study, it 
strengthens the generality of the findings and thus. the external 
validity. The main threat to external validity is the use of the 
single subject design. because the subject chosen was not 
entirely representative of all oeD patients. However, since the 
experiment was meant only as a first-phase pilot study to 
indicate the necessity of future studies in the area, the design 
seems appropriate. Overall, the study provides a good balance 
between internal and external 'validity by incorporating 
standardized testing scales and a naturalistic environment for 
exposure. 
Although the hypothesis was not upheld by the results of 
this study, future studies in the area are necessary to determine 
if combined treatment for obsessive-compulsive disorder (as well 
as other anxiety disorders) is a viable alternative to exposure 
and response prevention alone. Future studies must employ more 
that one subject as well as subjects of differing ages, treatment 
histories, and oeD severities. It might also be necessary to 
experiment with varying doses of the drug and the times at which 
the drug is administered. Hopefully, such experiments wi 11 
discover a method of combining benzodiazepines such as alprazolam 
with exposure and response prevention which will effectively 
alleviate the subject's anxiety without resulting in the 
occurrence of state-dependent learning. Such a method would 
provide relief to the many obsessive-compulsive disorder 
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sufferers who have failed to benefit from either pharmacotherapy 
nlone or exposure and response prevention alone. 
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Figure Caption 
Figure 1. Mean S.U.D.S. scores as a function of trials during 
the drug condition. Each bar represents the ten minute means 
from the average of the two drug conditions. Each line 
represents the standard error of the mean. BL is the baseline, 
D1-3 are the three trials of the drug days, and S1-3 are the 
three trials of the state-dependent days. 
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Figure Caption 
Mean S.U.D.S. ~corcs as u function of trials during 
the placebo condition. Each bar represents the ten minute means 
from the average of the two placebo conditions. Each line 
represents the standard error of the mean. BL is the baseline, 
Pl-3 are the three trials of the placebo days, and Sl-3 are the 
three trials of the state-dependent days. 
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